S&P 500 Falls 1%; Accenture Posts Upbeat Earnings

U.S. equities traded broadly lower on Thursday, with the Nasdaq Composite falling over 1% alongside declines in the Dow and S&P 500, despite a mixed economic picture. Key data included a 2.9% rise in durable goods orders, a shrinking trade deficit, and lower jobless claims, contrasting with a 0.2% decline in wholesale inventories and robust Q2 GDP growth of 3.8%. In corporate news, Accenture exceeded Q4 earnings and sales estimates, while CarMax shares dropped 23% after missing Q2 forecasts, and PepGen, SciSparc, and Plus Therapeutics posted significant gains on company-specific announcements.

Analysis

U.S. equity markets exhibited broad weakness mid-session, with the Nasdaq Composite leading declines with a 1.19% drop, while the S&P 500 and Dow fell 1% and 0.64% respectively. This market downturn occurred despite a series of robust U.S. economic reports, including a 2.9% monthly surge in durable goods orders against expectations of a 0.5% fall, a decline in initial jobless claims to 218,000, and an upward revision of Q2 GDP growth to an annualized 3.8%. This divergence suggests investor concerns may be overriding positive economic data. At the corporate level, performance was highly bifurcated. Accenture (ACN) posted better-than-expected Q4 results with EPS of $3.03 and sales of $17.60 billion, beating consensus. However, the market severely punished negative earnings news, as evidenced by CarMax (KMX) shares plummeting 23% after missing both EPS and sales estimates. Conversely, significant gains were seen in speculative names on company-specific catalysts, including SciSparc (SPRC) surging 101% on a new tech initiative and PepGen (PEPG) jumping 89% after pricing a public offering. Sector-wise, a clear rotation was visible with energy shares gaining 0.5% while healthcare stocks fell 1.4%, reflecting shifting investor allocations amid the wider market sell-off.

Key Decisions for Investors

• The market's negative reaction to strong economic data, such as the 3.8% Q2 GDP growth and a 2.9% rise in durable goods orders, suggests investors may be pricing in a more hawkish central bank response; monitor upcoming inflation data and Fed commentary closely.
• Given the severe 23% decline in CarMax (KMX) on an earnings miss versus a modest reaction to Accenture's (ACN) beat, investors should be cautious heading into earnings season as the market appears to be punishing negative surprises more severely than rewarding positive ones.
• The triple-digit rally in SciSparc (SPRC) and the 89% gain in PepGen (PEPG) indicate that high-risk appetite for event-driven, small-cap stocks persists, presenting high-beta opportunities but also demanding caution due to extreme volatility.
• Consider re-evaluating sector exposures, as the divergence between the outperforming energy sector (+0.5%) and the underperforming healthcare sector (-1.4%) highlights a clear rotational trend that may continue in the current macro environment.